These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1101 related items for PubMed ID: 16277686

  • 1. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
    Bianchi A, Moulin D, Sebillaud S, Koufany M, Galteau MM, Netter P, Terlain B, Jouzeau JY.
    Arthritis Res Ther; 2005; 7(6):R1325-37. PubMed ID: 16277686
    [Abstract] [Full Text] [Related]

  • 2. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
    Sawano H, Haneda M, Sugimoto T, Inoki K, Koya D, Kikkawa R.
    Kidney Int; 2002 Jun; 61(6):1957-67. PubMed ID: 12028436
    [Abstract] [Full Text] [Related]

  • 3. Oxidative stress-induced expression of HSP70 contributes to the inhibitory effect of 15d-PGJ2 on inducible prostaglandin pathway in chondrocytes.
    Bianchi A, Moulin D, Hupont S, Koufany M, Netter P, Reboul P, Jouzeau JY.
    Free Radic Biol Med; 2014 Nov; 76():114-26. PubMed ID: 25106704
    [Abstract] [Full Text] [Related]

  • 4. Effect of peroxisome proliferator activated receptor (PPAR)gamma agonists on prostaglandins cascade in joint cells.
    Moulin D, Poleni PE, Kirchmeyer M, Sebillaud S, Koufany M, Netter P, Terlain B, Bianchi A, Jouzeau JY.
    Biorheology; 2006 Nov; 43(3,4):561-75. PubMed ID: 16912428
    [Abstract] [Full Text] [Related]

  • 5. Expression and regulation of microsomal prostaglandin E synthase-1 in human osteoarthritic cartilage and chondrocytes.
    Li X, Afif H, Cheng S, Martel-Pelletier J, Pelletier JP, Ranger P, Fahmi H.
    J Rheumatol; 2005 May; 32(5):887-95. PubMed ID: 15868626
    [Abstract] [Full Text] [Related]

  • 6. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes.
    Fahmi H, Di Battista JA, Pelletier JP, Mineau F, Ranger P, Martel-Pelletier J.
    Arthritis Rheum; 2001 Mar; 44(3):595-607. PubMed ID: 11263774
    [Abstract] [Full Text] [Related]

  • 7. Signal pathways involved in the regulation of prostaglandin E synthase-1 in human gingival fibroblasts.
    Yucel-Lindberg T, Olsson T, Kawakami T.
    Cell Signal; 2006 Dec; 18(12):2131-42. PubMed ID: 16766159
    [Abstract] [Full Text] [Related]

  • 8. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D, Bianchi A, Boyault S, Sebillaud S, Koufany M, Francois M, Netter P, Jouzeau JY, Terlain B.
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [Abstract] [Full Text] [Related]

  • 9. 15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways.
    Boyault S, Simonin MA, Bianchi A, Compe E, Liagre B, Mainard D, Bécuwe P, Dauça M, Netter P, Terlain B, Bordji K.
    FEBS Lett; 2001 Jul 13; 501(1):24-30. PubMed ID: 11457450
    [Abstract] [Full Text] [Related]

  • 10. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
    Cuzzocrea S, Pisano B, Dugo L, Ianaro A, Patel NS, Di Paola R, Genovese T, Chatterjee PK, Di Rosa M, Caputi AP, Thiemermann C.
    Br J Pharmacol; 2003 Sep 13; 140(2):366-76. PubMed ID: 12970094
    [Abstract] [Full Text] [Related]

  • 11. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637.
    Haslmayer P, Thalhammer T, Jäger W, Aust S, Steiner G, Ensinger C, Obrist P.
    Int J Oncol; 2002 Oct 13; 21(4):915-20. PubMed ID: 12239635
    [Abstract] [Full Text] [Related]

  • 12. Activation of peroxisome proliferator-activated receptor gamma inhibits interleukin-1beta-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1.
    Cheng S, Afif H, Martel-Pelletier J, Pelletier JP, Li X, Farrajota K, Lavigne M, Fahmi H.
    J Biol Chem; 2004 May 21; 279(21):22057-65. PubMed ID: 15023995
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
    Farrajota K, Cheng S, Martel-Pelletier J, Afif H, Pelletier JP, Li X, Ranger P, Fahmi H.
    Arthritis Rheum; 2005 Jan 21; 52(1):94-104. PubMed ID: 15641079
    [Abstract] [Full Text] [Related]

  • 14. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma).
    Patel KM, Wright KL, Whittaker P, Chakravarty P, Watson ML, Ward SG.
    Cell Signal; 2005 Sep 21; 17(9):1098-110. PubMed ID: 15993751
    [Abstract] [Full Text] [Related]

  • 15. Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells.
    Kaplan J, Cook JA, O'Connor M, Zingarelli B.
    Shock; 2007 Dec 21; 28(6):722-726. PubMed ID: 17621259
    [Abstract] [Full Text] [Related]

  • 16. Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2.
    Petrova TV, Akama KT, Van Eldik LJ.
    Proc Natl Acad Sci U S A; 1999 Apr 13; 96(8):4668-73. PubMed ID: 10200320
    [Abstract] [Full Text] [Related]

  • 17. The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma.
    Giri S, Rattan R, Singh AK, Singh I.
    J Immunol; 2004 Oct 15; 173(8):5196-208. PubMed ID: 15470065
    [Abstract] [Full Text] [Related]

  • 18. PPARgamma inhibition of cyclooxygenase-2, PGE2 synthase, and inducible nitric oxide synthase in cardiac myocytes.
    Mendez M, LaPointe MC.
    Hypertension; 2003 Oct 15; 42(4):844-50. PubMed ID: 12885795
    [Abstract] [Full Text] [Related]

  • 19. Membrane-associated prostaglandin E synthase-1 is upregulated by proinflammatory cytokines in chondrocytes from patients with osteoarthritis.
    Kojima F, Naraba H, Miyamoto S, Beppu M, Aoki H, Kawai S.
    Arthritis Res Ther; 2004 Oct 15; 6(4):R355-65. PubMed ID: 15225371
    [Abstract] [Full Text] [Related]

  • 20. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
    Zingarelli B, Hake PW, Mangeshkar P, O'Connor M, Burroughs TJ, Piraino G, Denenberg A, Wong HR.
    Shock; 2007 Nov 15; 28(5):554-63. PubMed ID: 17589386
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.